Journal of Psychoactive Drugs

Papers
(The TQCC of Journal of Psychoactive Drugs is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015–202035
Pathways to Peer Support in Sober Living Houses: The Importance of Social Model Environments and Helping Behaviors23
Cannabis for Healing in a Native Community Clinic: Development and Results from an Informatics Research Tool23
Impact of a Naturalistic Psychedelic Experience on Smoking: A Retrospective Survey19
Methamphetamine-Induced Wakefulness and Sleep Management: A Qualitative Analysis of Online Narratives17
Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies17
Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health16
Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals: Prevalence, Predictors, and Emotional Valence15
Construction and Standardization of Perceived Shame Scale for Young Adults with Paternal Substance Use Disorder in Pakistan14
Religion, Psychedelics, Risky Behavior, and Violence14
Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders13
Selection Bias in Psychedelic Research: Comparing Self-Reported Quality-Of-Life Impact Between Enthusiasts and a General Population Sample13
Suicide Attempts in an Italian Population with Cannabis Use Disorders: Results of a Follow-Up Study13
A Meta-Analysis of Functional Neuroimaging Studies of Ketamine Administration in Healthy Volunteers13
Inhaled Dimethyltryptamine (DMT): Use Patterns and Predictors of Consumption Frequency13
The Epidemiology of Psychedelic Use Among United States Military Veterans13
Survey of U.S. Residents and Their Usage of Electronic Cigarettes with Drugs Other Than Nicotine13
Naturalistic Psychedelic Use: A World Apart from Clinical Care12
A Cross-Sectional Survey Investigating Māori and Non-Māori Cancer Patients’ Views on Psychedelic-Assisted Therapy in Aotearoa New Zealand11
Religious Social Integration, Psychedelics, and Psychological Distress11
Questions and Concerns About MDMA-Assisted Therapy (MDMA-AT) in Veterans with PTSD Symptoms11
Prescription and Non-Prescription Anxiolytic Use is Linked to Personal Characteristics Among University Students11
Role Strain Among Parents Who are Medical Cannabis Patients in Pennsylvania11
Comparison of Emotional Processing Between Patients with Substance Use Disorder and Those with Dual Diagnosis: Relationship with Severity of Dependence and Use During Treatment11
From Policy to Perception: Do Public Views on UK Drug Policy Shape Attitudes Toward Psychedelics?10
Psychedelic Microdosing among Young Adults from Southern California10
Experimental Test of Perceptions of Psychedelics by Therapeutic and Recreational Use10
Understanding the Experience of Ketamine-Assisted Therapy and the Importance of Context10
Interactions Between Depressive Symptoms, Childhood Trauma, and Drug Craving in Chinese Men with Methamphetamine Use Disorder: A Network Analysis10
Self-Forgiveness and Gratitude in Recovery from Substance Use Disorders10
Effect of Social Vulnerability on Cocaine-Related Mortality Rates in U.S. Counties9
Mystical Experiences as Catalysts in Ketamine-Assisted Psychotherapy: A Case Study9
Not Losing Momentum: Cross-Sectional Insights into Ibogaine Clinical Trials9
Minor Cannabinoid Use Among Medical Cannabis Patients9
The Relationship Between Alcohol Use, Blood Alcohol Concentration, and Road Traffic Accidents: A Scoping Review9
Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use9
Psychedelic Research and Therapeutic Practices: Embracing Communities, Groups, and Traditional Knowledge9
Ayahuasca Therapy: Possible Reduction of Suicidal Ideation in Treatment-Resistant Depression – A Systematic Review9
Cortisol/DHEA-S Ratio Normalization by Buprenorphine: Associations with Stress, Coping, and Social Support in Youth with Opioid Use Disorder9
Latent Clusters of Peer Behaviors in Childhood and Relevance for Understanding Substance Use in Early Adolescence9
The Protective Role of Savoring on Coping Motives for Cannabis Use and Consequences8
Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset8
Delta-8- and Delta-9-THC Use Frequency, Use Motives, and Mental Health Outcomes8
Solitary Cannabis Use and Related Consequences Among College Students During the COVID-19 Pandemic8
State-Level Support for Recovery Housing: Results from a National Collaborative Study of U.S. Single State Agencies8
N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q)8
Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress8
Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study8
Differences in Online Descriptions and Marketing of Derived Intoxicating Cannabis Products8
Psychedelic Use and Behavioral Addictions8
Healing Words: Effects of Psychoeducation on Likelihood to Seek and Refer Psychedelic-Assisted Psychotherapy Among BIPOC Individuals7
Therapeutic Protocols Using Ketamine and Esketamine for Depressive Disorders: A Systematic Review7
Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences7
Vermont Primary Care Provider Perspectives on Psychedelics — A Cross-Sectional Study7
Examining Volunteer Bias in Psychedelic Research7
Outcomes Among Sober Living House Residents Who Relapse: Role of Recovery Capital6
Association Between Lifetime Hallucinogen Use and Valvular Heart Disease: Findings from the All of Us Research Program6
Identification of Cannabis Product Characteristics and Pricing on Dark Web Markets6
Cultural Adaptation of Overdose Education Programs: Recommendations from Black Americans with Lived Experience of Opioid and Stimulant Use6
Does the Perception of Risk Associated with Psychedelics Use Differ in Physicians According to Their Belief of Effectiveness?6
Psychiatric Residents’ Perspectives on Psychedelics and Psychedelic Assisted Therapy6
Therapeutic Effects of Ceremonial Ayahuasca Use for Methamphetamine Use Disorders and Other Mental Health Challenges: Case Studies in an Indigenous Community in Sonora, Mexico6
Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review6
Cannabis Expectancies for Sleep Modulate Discrepancies Between Subjective and Objective Sleep Outcomes: A Pilot Study6
MDMA-Assisted Psychotherapy for PTSD: A Systematic Review of Randomized Control Trials6
Kratom Retail Availability in Fort Worth, Texas6
Public Knowledge, Perceptions, and Behavioral Intention Regarding Medical Cannabis in Belgium6
Psychedelic Terminology Preference in the 2024 National Survey Investigating Hallucinogenic Trends (NSIHT)6
The Association of Substance Use Disorder (SUD) Type and Other Factors in SUD Recognition Among U.S. Adults5
Approach Without Liking: The Effects of Smoking-Related Settings on Implicit Liking Attitudes and Approach Tendencies Toward Smoking5
Social Learning Theory and Gateway Hypothesis as a Causal Pathway Linking Rule-Breaking Peer Association to Marijuana Use via Nicotine Vaping5
Prevalence of Substance Use Among Asian Sexual Minority Individuals in the United States, 2015-20205
Economic Stress, Mental Health, and Drug Use: Regional Insights from Taiwan5
What Differentiates Dropping Out from Remaining in a Brief Intervention for Problematic and Dependent Methamphetamine Users?5
How Personal Attitudes About Legalizing Cannabis and Corresponding State Laws Affect the Stigma of Cannabis Use5
Cannabis Dependence Among Georgian Small-Scale Cannabis Growers: Results of a Cross-Sectional Online Survey5
Psilocybin’s Potential Mechanisms in the Treatment of Depression: A Systematic Review5
“How Do I Learn More About this?”: Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics5
Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption5
Attitudes of Mental Healthcare Professionals Towards the Use of Psychedelics in the Treatment of Substance Use Disorders: A Systematic Review5
Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts5
Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine5
Sweating for Sobriety: Exploring the Relationship Between Exercise Engagement and Substance Use Disorders5
Death Anxiety Among Users and Non-Users of Psychedelics5
0.10697317123413